Corcept Therapeutics Incorporated (CORT) ownership: Top institutional holder: BlackRock, Inc. ($489.82M). Insider activity: Net Seller (4 buys, 16 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 12151276.00 | $489.82M | 2026-03-31 |
| VANGUARD GROUP INC | 9494822.00 | $330.42M | 2025-12-31 |
| INGALLS & SNYDER LLC | 7608716.00 | $306.71M | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 5682783.00 | $229.07M | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4820568.00 | $194.32M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4077196.00 | $164.35M | 2026-03-31 |
| Parallel Advisors, LLC | 3977404.00 | $160.33M | 2026-03-31 |
| STATE STREET CORP | 3200946.00 | $129.03M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-06-02 | |
| Sell | null | 2026-06-02 |
Back to CORT overview · CORT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.